|
|
|
40
|
2141AK
|
SPIRONOLACTONE 25MG TAB (KWA/ATB)
|
SPIRONOLACTONE
|
SPIRONOLACTONE
|
10X10
|
A
|
7.45
|
0.07
|
TABLET
|
120
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-30
|
|
|
|
40
|
2141X
|
SPIROLON 25MG TAB (REM/SBI) SPIRONOLACTONE
|
SPIRONOLACTONE
|
SPIROLON
|
1000'S
|
A
|
79.43
|
0.08
|
TABLET
|
120
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
2141X
|
SPIROLON 25MG TAB (REM) SPIRONOLACTONE
|
SPIRONOLACTONE
|
SPIROLON
|
1000'S
|
A
|
74.86
|
0.0749
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2023-10-27
|
|
|
|
42
|
2141X
|
SPIROLON 25MG TAB (REM) SPIRONOLACTONE
|
SPIRONOLACTONE
|
SPIROLON
|
1000'S
|
A
|
75.57
|
0.08
|
TAB
|
120
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
21423
|
SPIROLON 100MG TAB (REM/SBI) SPIRONOLACTONE
|
SPIRONOLACTONE
|
SPIROLON
|
10x10
|
A
|
26.69
|
0.27
|
TABLET
|
120
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
21423
|
SPIROLON 100MG TAB (REM) SPIRONOLACTONE
|
SPIRONOLACTONE
|
SPIROLON
|
10x10
|
A
|
24.6
|
0.246
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
21423
|
SPIROLON 100MG TAB (REM) SPIRONOLACTONE
|
SPIRONOLACTONE
|
SPIROLON
|
10x10
|
A
|
38.19
|
0.38
|
TAB
|
120
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
2142N
|
ALDACTONE 100MG TAB (PFI/STO) SPIRONOLACTONE
|
SPIRONOLACTONE
|
ALDACTONE
|
10'S
|
C
|
19.08
|
1.91
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
2142N
|
ALDACTONE 100MG TAB (PFI) SPIRONOLACTONE (C)
|
SPIRONOLACTONE
|
ALDACTONE
|
10'S
|
C
|
17.81
|
1.7805
|
TAB
|
120
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
21431
|
INSPRA 50MG TAB (PFI/STO) EPLERENONE
|
EPLERENONE
|
INSPRA
|
30'S
|
B
|
97.91
|
3.26
|
TABLET
|
60
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
21431
|
INSPRA 50MG TAB (PFI) EPLERENONE (C)
|
EPLERENONE
|
INSPRA
|
30'S
|
C
|
100.47
|
3.349
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
21432
|
INSPRA 25MG TAB (PFI/STO) EPLERENONE
|
EPLERENONE
|
INSPRA
|
30'S
|
B
|
88.70
|
2.96
|
TABLET
|
60
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
21432
|
INSPRA 25MG TAB (PFI) EPLERENONE (C)
|
EPLERENONE
|
INSPRA
|
30'S
|
C
|
91.31
|
3.0436
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
41
|
21433
|
INSPRA 50MG TAB (PFI) EPLERENONE (C)
|
EPLERENONE
|
INSPRA
|
30'S
|
C
|
100.47
|
3.349
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
41
|
21434
|
INSPRA 25MG TAB (PFI) EPLERENONE (C)
|
EPLERENONE
|
EPNONE
|
30'S
|
C
|
91.31
|
3.0436
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
41
|
21435
|
EPNONE 50MG TAB (MSN) EPLERENONE (B)
|
EPLERENONE
|
EPNONE
|
30'S
|
B
|
21.39
|
0.7131
|
TAB
|
60
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
41
|
21436
|
EPNONE 25MG TAB (MSN) EPLERENONE (B)
|
EPLERENONE
|
EPNONE
|
30'S
|
B
|
12.64
|
0.4213
|
TAB
|
60
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
21437
|
EPLETUS 25MG TAB (JLP) EPLERENONE
|
EPLERENONE
|
EPLETUS
|
10X10
|
BQ
|
39.42
|
0.39
|
TAB
|
60
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
21617
|
HYALASE 1500IU INJ (CPP/COL) HYALURONIDASE
|
HYALURONIDASE
|
HYALASE
|
1500IU
|
BQ
|
42.95
|
42.95
|
INJECTION
|
0
|
AMP
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
COLLINS LTD
|
|
4400
|
ENZYMES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ENZYMES
|
|
|
|
|
40
|
2161D
|
HYALURONIDASE 1500IU INJ (SLS/AHI)
|
HYALURONIDASE
|
HYALURONIDASE
|
10X10ML
|
BQ
|
111.94
|
11.19
|
INJECTION
|
0
|
AMP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4400
|
ENZYMES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ENZYMES
|
|